SCYNEXIS, Inc. to Present at Jefferies 2015 Healthcare Conference

Download as PDF

RESEARCH TRIANGLE PARK, N.C., May 26, 2015 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that Marco Taglietti, M.D., SCYNEXIS' Chief Executive Officer, will present at the Jefferies 2015 Healthcare Conference at the Grand Hyatt in New York City on June 1, 2015, at 8:00 a.m. ET.

A live webcast will be available on the investor's section of the Company's website: www.scynexis.com. A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.

About SCYNEXIS, Inc.

SCYNEXIS is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. We are developing our lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of serious and life-threatening invasive fungal infections in humans. For more information, visit www.scynexis.com.

CONTACT: Media Relations
         Heather Savelle
         MacDougall Biomedical Communications
         Tel: 781.235.3060
         hsavelle@macbiocom.com

         Investor Relations
         Jillian Connell
         The Trout Group LLC
         Tel: 646.378.2956
         jconnell@troutgroup.com
Source: SCYNEXIS, Inc.

Released May 26, 2015